Maghreb Oxygene SA

Maghreb Oxygene SA maintains a debt-to-equity ratio of 1.49, indicating a moderate reliance on debt financing, and a current ratio of 3.42, suggesting strong short-term liquidity. However, the company's free cash flow is negative at -40.57 million MAD, and capital expenditures are substantial at -77.62 million MAD, reflecting ongoing investment in operations. The company's profitability is modest, with a return on equity of 4.84% and a return on assets of 1.59%, both below the industry median for Commodity Chemicals. Operating income of 12.52 million MAD and net income of 15.45 million MAD indicate limited margin expansion, with gross profit at 144.75 million MAD. Revenue is concentrated in Morocco, with no disclosed international segments, and the company operates in a single business line focused on industrial and medical gases. This lack of diversification increases exposure to local economic and regulatory shifts. Looking ahead, revenue is expected to grow by 4.5% in the current fiscal year and 3.2% in the next, driven by stable demand in the industrial and healthcare sectors. However, the company's capital expenditures are expected to remain high, which may constrain near-term profitability. The company faces moderate liquidity risk due to negative net cash after subtracting total debt, and while dilution risk is currently low, the potential for future equity issuance remains if capital needs increase. Adjustments in valuation models have not yet reflected recent operational changes. Recent filings and transcripts highlight ongoing investments in production capacity and a focus on expanding the medical gases segment. No major regulatory or legal issues have been disclosed in the latest reports.